About sotera health co - SHC
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.
SHC At a Glance
Sotera Health Co.
9100 South Hills Boulevard
Broadview Heights, Ohio 44147-3518
| Phone | 1-440-262-1410 | Revenue | 1.16B | |
| Industry | Medical Specialties | Net Income | 77.95M | |
| Sector | Health Technology | 2025 Sales Growth | 5.741% | |
| Fiscal Year-end | 12 / 2026 | Employees | 3,000 | |
| View SEC Filings |
SHC Valuation
| P/E Current | 48.254 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 64.829 |
| Price to Sales Ratio | 4.342 |
| Price to Book Ratio | 8.277 |
| Price to Cash Flow Ratio | 17.86 |
| Enterprise Value to EBITDA | 12.568 |
| Enterprise Value to Sales | 5.998 |
| Total Debt to Enterprise Value | 0.326 |
SHC Efficiency
| Revenue/Employee | 387,872.333 |
| Income Per Employee | 25,981.667 |
| Receivables Turnover | 6.601 |
| Total Asset Turnover | 0.353 |
SHC Liquidity
| Current Ratio | 2.458 |
| Quick Ratio | 2.22 |
| Cash Ratio | 1.388 |
SHC Profitability
| Gross Margin | 52.835 |
| Operating Margin | 35.779 |
| Pretax Margin | 12.677 |
| Net Margin | 6.699 |
| Return on Assets | 2.365 |
| Return on Equity | 15.42 |
| Return on Total Capital | 2.707 |
| Return on Invested Capital | 2.789 |
SHC Capital Structure
| Total Debt to Total Equity | 375.169 |
| Total Debt to Total Capital | 78.955 |
| Total Debt to Total Assets | 66.802 |
| Long-Term Debt to Equity | 371.342 |
| Long-Term Debt to Total Capital | 78.149 |